elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Octreotide
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Octreotide
RIS
0.002
(Research Intensity Score)
Papers
278
Top papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 · 364 citations
Auger electrons for cancer therapy – a review
2019 · 652 citations
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
2019 · 437 citations
[ 177 Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study.
2024 · 45 citations
Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity
2021 · 89 citations
Newest papers
Chylothorax after pediatric cardiac surgery: pathophysiology, diagnosis, and evolving management strategies
2026
Carcinoid syndrome revealed by chronic diarrhea and isolated severe tricuspid regurgitation
2026
Clinical outcomes of medical therapy, EUS-guided ethanol ablation, and surgical resection in insulinoma: a clinical epidemiology study
2026
Ex Vivo drug sensitivity in patient-derived 3D cultures in acromegaly and its association with clinical predictors
2026
Metastatic Unfunctional Pancreatic Neuroendocrine Tumor in Lynch Syndrome
2026
A sample from the 100 top papers behind Octreotide.
Create a free account to browse them all →
Octreotide's history
Research intensity over time
Explore Octreotide's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Octreotide's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link